6-Substituted Benzimidazoles as New Nonpeptide ...ACS Publications
pubs.acs.org
von UJ Ries · · Zitiert von: 287 — van Meel, Wolfgang Wienen, and Norbert H. Hauel* *. Departments of ChemicalResearch, Biochemical Research, and Biological Research, Dr. Karl Thomae GmbH ... von UJ Ries · · Zitiert von: 287 — van Meel, Wolfgang Wienen, and Norbert H. Hauel* *. Departments of ChemicalResearch, Biochemical Research, and Biological Research, Dr. Karl Thomae GmbH ...
6-Substituted Benzimidazoles as New Nonpeptide ...American Chemical Society
pubs.acs.org
von UJ Ries · · Zitiert von: 276 — Jacobus C. A. van Meel, Wolfgang Wienen, and Norbert H. Hauel* *. Departments of ChemicalResearch, Biochemical Research, and Biological Research, ...
Structure-Based Design of Novel Potent Nonpeptide ...American Chemical Society ·
pubs.acs.org
von NH Hauel · · Zitiert von: 559 — Norbert H. Hauel,* Herbert Nar, Henning Priepke, Uwe Ries, Jean-Marie Stassen, and Wolfgang Wienen. Boehringer Ingelheim Pharma KG, Research Division, ... › doi › pdf
. . Michael Entzeroth*, Henri N. Doods, Heike A. Wieland ...ScienceDirect.com
www.sciencedirect.com
von M Entzeroth · · Zitiert von: 123 — Wieland and Wolfgang Wienen. Biochemical Research, Dr. Karl Thomae GmbHD Biberach, Germany. (Submitted September. 6, von M Entzeroth · · Zitiert von: 123 — Wieland and Wolfgang Wienen. Biochemical Research, Dr. Karl Thomae GmbHD Biberach, Germany. (Submitted September. 6,
Structural Basis for Inhibition Promiscuity of Dual Specific ...CORE
core.ac.uk
von H Nar · · Zitiert von: 114 — Jean-Marie Stassen, Wolfgang Wienen,. Henning W.M. Priepke, Iris K. Kauffmann,. Uwe J. Ries, and Norbert H. Hauel. Department of Medicinal Chemistry and. von H Nar · · Zitiert von: 114 — Jean-Marie Stassen, Wolfgang Wienen,. Henning W.M. Priepke, Iris K. Kauffmann,. Uwe J. Ries, and Norbert H. Hauel. Department of Medicinal Chemistry and.
Reduction of cardiac hypertrophy in TGR(mREN2)27 by ...Springer
link.springer.com
von M Böhm · · Zitiert von: 84 — Wolfgang Wienen,; Detlev Ganten & … Michael Bader. Show authors Wolfgang Wienen. Authors. Manfred Böhm. View author publications. You can also ... von M Böhm · · Zitiert von: 84 — Wolfgang Wienen,; Detlev Ganten & … Michael Bader. Show authors Wolfgang Wienen. Authors. Manfred Böhm. View author publications. You can also ...
Alle Infos zum Namen "Wolfgang Wienen"
Antithrombotic and anticoagulant effects of the direct ...Journal of Thrombosis and Haemostasis
www.jthjournal.org
von W WIENEN · · Zitiert von: 69 — Wolfgang Wienen, Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Strasse, D‐ Biberach, Germany. Tel.: + von W WIENEN · · Zitiert von: 69 — Wolfgang Wienen, Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Strasse, D‐ Biberach, Germany. Tel.: +
Dabigatran Acylglucuronide, the Major Human Metabolite of ...Drug Metabolism & Disposition
dmd.aspetjournals.org
von T Ebner · · Zitiert von: 110 — Thomas Ebner, Klaus Wagner, and Wolfgang Wienen. Department of Drug Metabolism and Pharmacokinetics, Pulmonary Research, Analytical Development, Boehringer ... von T Ebner · · Zitiert von: 110 — Thomas Ebner, Klaus Wagner, and Wolfgang Wienen. Department of Drug Metabolism and Pharmacokinetics, Pulmonary Research, Analytical Development, Boehringer ...
Effects of telmisartan, hydrochlorothiazide and their ...CiNii
cir.nii.ac.jp
von W Wienen · · Zitiert von: 30 — Wolfgang Wienen: Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany, wolfgang. -ingelheim.com. Hans-Joachim Schierok ... von W Wienen · · Zitiert von: 30 — Wolfgang Wienen: Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany, wolfgang. -ingelheim.com. Hans-Joachim Schierok ...
Effects of the AT1-selective angiotensin II antagonist, ...Resuscitation Journal
www.resuscitationjournal.com
von HU Strohmenger · · Zitiert von: 17 — Lindner a,*, Wolfgang Wienen b, Josef Vogt a a Department of Anesthesiology and Critical Care Medicine, Uni6ersity of Ulm, Ulm, Germany b Department of ... von HU Strohmenger · · Zitiert von: 17 — Lindner a,*, Wolfgang Wienen b, Josef Vogt a a Department of Anesthesiology and Critical Care Medicine, Uni6ersity of Ulm, Ulm, Germany b Department of ...
O-28: Molecular basis for the insurmountable AT-1 receptor ...Oxford Academic
academic.oup.com
von MP Maillard · · Zitiert von: 1 — Wolfgang Wienen ,. Wolfgang Wienen. 1. Division of Hypertension and Vascular Medicine Lausanne University Hospital. ,. Lausanne. ,. Switzerland. 2. Dept ... von MP Maillard · · Zitiert von: 1 — Wolfgang Wienen ,. Wolfgang Wienen. 1. Division of Hypertension and Vascular Medicine Lausanne University Hospital. ,. Lausanne. ,. Switzerland. 2. Dept ...
Structure-based design of novel potent nonpeptide ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von NH Hauel · · Zitiert von: 593 — Wolfgang Wienen. Affiliation. 1 Boehringer Ingelheim Pharma KG, Research DivisionD Biberach/RISS, Germany. norbert.hauel@bc ... von NH Hauel · · Zitiert von: 593 — Wolfgang Wienen. Affiliation. 1 Boehringer Ingelheim Pharma KG, Research DivisionD Biberach/RISS, Germany. norbert.hauel@bc ...
Effects of an angiotensin II antagonist on organ perfusion ...National Institutes of Health (.gov)
www.ncbi.nlm.nih.gov
von HU Strohmenger · · Zitiert von: 4 — ... on organ perfusion during the post-resuscitation phase in pigs. Hans-Ulrich Strohmenger,1 Karl H Lindner,1Wolfgang Wienen,2 and Peter Radermacher1 ...
The discovery of dabigatran etexilate. - Abstracteuropepmc.org
europepmc.org
von J van Ryn · · Zitiert von: 56 — Joanne van Ryn,1,* Ashley Goss,2 Norbert Hauel,3Wolfgang Wienen,4 Henning Priepke,3 Herbert Nar,5 and Andreas Clemens6 ...
sortiert nach Relevanz / Datum